Heather A. Berger
CIK: 0001751873
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DSGN
Design Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Berger Heather A.
Berger Heather A. (SEC CIK 0001751873) files insider reports with the SEC as Director of Design Therapeutics, Inc. (DSGN).
Signal8 holds 2 ownership filings by Berger Heather A., all Form 4s, filed between Jun 12, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Berger Heather A.'s filings is in CARLSBAD, CA.
Recent filings by Berger Heather A.
Other insiders filing for Design Therapeutics, Inc. (DSGN)
- George Simeon, Director
- Schmid John P., Director
- LAPPE RODNEY W, Director
- Gover Justin D., Director
- Shapiro David, Director
- Storgard Chris, Chief Medical Officer